Metastatic Lung Cancer

Metastatic Lung Cancer - most related articles:

- Lilly's lung cancer drug Alimta is approved in US - 6.5
- Eli Lilly's Alimta approvad for lung cancer - 5.6
- Avastin bevacizumab approval revoked to treat breast cancer in US - 5.1
- Quitting smoking doubles survival in lung cancer patients - 5
- RNA may stop breast cancer spread - 4.9
- Urine test predicts lung cancer risk in smokers - 4.8
- Avastin found effective in advanced breast cancer patients - 4.8
- Genentech's Avastin with chemotherapy approved for advanced breast cancer - 4.7
- Breast cancer drug Abraxane promising for malignant melanoma treatment - 4.6
- FDA panel votes to revoke approval for Avastin for advanced breast cancer - 4.6

Metastatic Lung Cancer articles

Lilly's lung cancer drug Alimta is approved in US
Eli Lilly's lung cancer drug Alimta (pemetrexed) -- the first drug available for maintenance therapy of advanced or metastatic lung cancer, is approved by the U.S. Food and Drug Administration, USA.

Eli Lilly's Alimta approvad for lung cancer
Eli Lilly and Company (NYSE: LLY) announced that it received approval from the U.S. Food and Drug Administration (FDA) for the use of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, in the first-line treatment of locally-advanced and metastatic non-small cell lung cancer (NSCLC), for patients with nonsquamous histology.

2 Metastatic Lung Cancer articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
5.21